Asahi Kasei Therapeutics Corp - Company Profile

Powered by

All the sales intelligence you need on Asahi Kasei Therapeutics Corp in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Asahi Kasei Therapeutics Corp fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Asahi Kasei Therapeutics Corp.

Back to companies

Asahi Kasei Therapeutics Corp: Deals

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

View up-to-date information on Asahi Kasei Therapeutics Corp’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.

Number of Deals

image for loader

Deal Value ($M)

Image for Loader
Gain insight into company strategy with premium access to M&A activity Gain insight into company strategy with premium access to M&A activity Learn more

Latest Deals

Announced Date Headline Deal Type Acquirers/Investors/Surviving Entity Issuer/Partner/Target
15 Aug 2023 Asahi Kasei Pharma Corp Enters Manufacturing Agreement with AGC Biologics for monoclonal antibody Contract Service Agreement Asahi Kasei Pharma Corp
AGC Biologics Inc  

06 Dec 2022 Pulmocide Raises USD52 Million in Extended Series C Financing Venture Financing
Adjuvant Capital Inc  

JJDC, Inc.  

SR One Ltd  

Jeito Capital  

Vivo Capital LLC  

F-Prime Inc  

Asahi Kasei Pharma Corp
Pictet Alternative Advisors SA  

Cystic Fibrosis Foundation  

IP Group Plc
Longwood Fund Management LLC  

SV Health Investors UK Ltd  

Pulmocide Ltd  

15 Sep 2022 Asahi Kasei Pharma Enters into Distribution Agreement with Swedish Orphan Biovitrum Japan Partnership -
Swedish Orphan Biovitrum Japan Co Ltd  

Asahi Kasei Pharma Corp
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
Explore the latest deals, partnerships, mergers & acquisitions when you unlock full profile Explore the latest deals, partnerships, mergers & acquisitions when you unlock full profile Learn more
Get in touch about GlobalData Explorer

Contact the team or request a demo to find out how our data can drive your business forward

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer